Reliability and Validity Study of the Turkish Version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)

Recruiting Observational Study
Idiopathic Parkinson Disease Dyskinesias Quality of Life
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
130 (estimated)
Sponsor
Izmir Bakircay University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The aim of this methodological study was to investigate the Turkish validity and reliability of the Parkinson's Disease Dyskinesia Scale (PDYS-26).The scale evaluates choreic dyskinesia.Measures the impact of dyskinesia on activities of daily living in patients with Parkinson's disease. Hypotheses of the Study: * Parkinson's Disease Dyskinesia Scale (PDYS-26) is reliable in Turkish. * Parkinson'…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Being diagnosed with idiopathic Parkinson's disease * H\&Y stage 1-3 * UPDRS dyskinesia item score ≥1 * Accepting to participate in the study Exclusion Criteria: * Diagnosis of atypical-secondary parkinsonism * Severe musculoskeletal, neurological and/or cardiopulmonary prob…
Contacts

Irem Tepe Bark, PT

+905537491143

fztiremtepe@gmail.com

CONTACT

Gulbin Ergin, PT, PhD

+90 232 493 00 00

gulbin.ergin@bakircay.edu.tr

CONTACT